The FDA approved Pfizer's Talzenna with Xtandi for men with metastatic prostate cancer that still responds to hormone therapy and carries DNA-repair gene mutations.
Merck and Moderna's personalized mRNA therapy intismeran, added to Keytruda, cut the risk of melanoma returning or death by 42% in a phase 3 trial presented at ESMO.
Flu hospitalizations are at the highest mid-October rate since 2010-11, CDC data show, with seniors hit hardest, H1N1 dominant and a new H5N1 case in Washington.
The uninsured rate for working-age adults rose to 11.2% in 2026 before Medicaid cuts begin, and half skipped care due to cost, Commonwealth Fund finds.
AAA expects 81.5 million Thanksgiving travelers. This guide helps older adults and caregivers pack medications, arrange assistance and plan for delays.